ABBV
Price
$181.97
Change
+$1.61 (+0.89%)
Updated
Mar 28, 6:59 PM EST
28 days until earnings call
GILD
Price
$73.25
Change
+$0.24 (+0.33%)
Updated
Mar 28, 6:59 PM EST
28 days until earnings call
Ad is loading...

Analysis and predictions ABBV vs GILD

Header iconABBV vs GILD Comparison
Open Charts ABBV vs GILDBanner chart's image
ABBVIE
Price$181.97
Change+$1.61 (+0.89%)
Volume$1.04M
CapitalizationN/A
Gilead Sciences
Price$73.25
Change+$0.24 (+0.33%)
Volume$5.01M
CapitalizationN/A
View a ticker or compare two or three
ABBV vs GILD Comparison Chart

Loading...

ABBVDaily Signal changed days agoGain/Loss if shorted
 
Show more...
GILDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ABBV vs. GILD commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABBV is a Hold and GILD is a StrongBuy.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (ABBV: $181.97 vs. GILD: $73.25)
Brand notoriety: ABBV and GILD are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ABBV: 19% vs. GILD: 69%
Market capitalization -- ABBV: $322.43B vs. GILD: $90.95B
ABBV [@Pharmaceuticals: Major] is valued at $322.43B. GILD’s [@Pharmaceuticals: Major] market capitalization is $90.95B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $87.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABBV’s FA Score shows that 4 FA rating(s) are green whileGILD’s FA Score has 2 green FA rating(s).

  • ABBV’s FA Score: 4 green, 1 red.
  • GILD’s FA Score: 2 green, 3 red.
According to our system of comparison, ABBV is a better buy in the long-term than GILD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABBV’s TA Score shows that 4 TA indicator(s) are bullish while GILD’s TA Score has 5 bullish TA indicator(s).

  • ABBV’s TA Score: 4 bullish, 4 bearish.
  • GILD’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, GILD is a better buy in the short-term than ABBV.

Price Growth

ABBV (@Pharmaceuticals: Major) experienced а +2.52% price change this week, while GILD (@Pharmaceuticals: Major) price change was +0.22% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.56%. For the same industry, the average monthly price growth was -3.24%, and the average quarterly price growth was -2.12%.

Reported Earning Dates

ABBV is expected to report earnings on Apr 25, 2024.

GILD is expected to report earnings on Apr 25, 2024.

Industries' Descriptions

@Pharmaceuticals: Major (+0.56% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
A.I.dvisor published
a Summary for ABBV with price predictions.
OPEN
A.I.dvisor published
a Summary for GILD with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ABBV($322B) has a higher market cap than GILD($91B). ABBV has higher P/E ratio than GILD: ABBV (66.95) vs GILD (16.22). ABBV YTD gains are higher at: 18.545 vs. GILD (-8.653). ABBV has higher annual earnings (EBITDA): 17.2B vs. GILD (10.5B). ABBV has more cash in the bank: 12.8B vs. GILD (7.26B). GILD has less debt than ABBV: GILD (25B) vs ABBV (59.4B). ABBV has higher revenues than GILD: ABBV (54.3B) vs GILD (27.1B).
ABBVGILDABBV / GILD
Capitalization322B91B354%
EBITDA17.2B10.5B164%
Gain YTD18.545-8.653-214%
P/E Ratio66.9516.22413%
Revenue54.3B27.1B200%
Total Cash12.8B7.26B176%
Total Debt59.4B25B238%
FUNDAMENTALS RATINGS
ABBV vs GILD: Fundamental Ratings
ABBV
GILD
OUTLOOK RATING
1..100
2668
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
3
Undervalued
PROFIT vs RISK RATING
1..100
429
SMR RATING
1..100
2840
PRICE GROWTH RATING
1..100
5050
P/E GROWTH RATING
1..100
785
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GILD's Valuation (3) in the Biotechnology industry is in the same range as ABBV (11) in the Pharmaceuticals Major industry. This means that GILD’s stock grew similarly to ABBV’s over the last 12 months.

ABBV's Profit vs Risk Rating (4) in the Pharmaceuticals Major industry is in the same range as GILD (29) in the Biotechnology industry. This means that ABBV’s stock grew similarly to GILD’s over the last 12 months.

ABBV's SMR Rating (28) in the Pharmaceuticals Major industry is in the same range as GILD (40) in the Biotechnology industry. This means that ABBV’s stock grew similarly to GILD’s over the last 12 months.

ABBV's Price Growth Rating (50) in the Pharmaceuticals Major industry is in the same range as GILD (50) in the Biotechnology industry. This means that ABBV’s stock grew similarly to GILD’s over the last 12 months.

ABBV's P/E Growth Rating (7) in the Pharmaceuticals Major industry is significantly better than the same rating for GILD (85) in the Biotechnology industry. This means that ABBV’s stock grew significantly faster than GILD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABBVGILD
RSI
ODDS (%)
Bearish Trend 1 day ago
48%
Bullish Trend 7 days ago
52%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
48%
Bullish Trend 1 day ago
53%
Momentum
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
50%
MACD
ODDS (%)
Bearish Trend 7 days ago
57%
Bullish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
51%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
54%
Advances
ODDS (%)
Bullish Trend 1 day ago
59%
Bullish Trend 1 day ago
53%
Declines
ODDS (%)
Bearish Trend 21 days ago
47%
Bearish Trend 3 days ago
49%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
47%
Bearish Trend 1 day ago
56%
Aroon
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
52%
View a ticker or compare two or three
Ad is loading...
ABBVDaily Signal changed days agoGain/Loss if shorted
 
Show more...
GILDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FSM3.720.10
+2.90%
FORTUNA Silver Mines
GOSS1.180.01
+0.85%
Gossamer Bio
KRC36.410.29
+0.80%
Kilroy Realty Corp
MPLX41.540.23
+0.56%
Mplx LP
BTOG4.01-0.09
-2.20%
Bit Origin Limited

GILD and

Correlation & Price change

A.I.dvisor indicates that over the last year, GILD has been loosely correlated with AMGN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if GILD jumps, then AMGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GILD
1D Price
Change %
GILD100%
+0.33%
AMGN - GILD
44%
Loosely correlated
-0.70%
BIIB - GILD
35%
Loosely correlated
-0.32%
BMY - GILD
34%
Loosely correlated
+1.84%
MRK - GILD
31%
Poorly correlated
+0.13%
JNJ - GILD
29%
Poorly correlated
+0.13%
More